Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01142414
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Testing effectiveness (Phase 2)Ended earlyNCT01316263
What this trial is testing

Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Eli Lilly and Company 21
Large-scale testing (Phase 3)Study completedNCT00751621
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

Who this might be right for
Primary Immunodeficiency (PID)
CSL Behring 40
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)UnknownNCT04170595
What this trial is testing

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

Who this might be right for
HER2-positive Breast Cancer
Genor Biopharma Co., Ltd. 132
Early research (Phase 1)WithdrawnNCT05519527
What this trial is testing

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Who this might be right for
Refractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04742153
What this trial is testing

MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)

Who this might be right for
Advanced or Metastatic Breast Cancer
Shanghai Miracogen Inc. 66
Testing effectiveness (Phase 2)Study completedNCT00268788
What this trial is testing

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Who this might be right for
Multifocal Motor Neuropathy
University of Aarhus 10
Testing effectiveness (Phase 2)Study completedNCT01895361
What this trial is testing

Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises

Who this might be right for
Sickle Cell Disease
Reprixys Pharmaceutical Corporation 198
Testing effectiveness (Phase 2)Study completedNCT02390596
What this trial is testing

Anakinra and Kawasaki Disease

Who this might be right for
Kawasaki DiseaseChildren
Assistance Publique - Hôpitaux de Paris 16
Testing effectiveness (Phase 2)UnknownNCT05173441
What this trial is testing

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

Who this might be right for
COVID-19
Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. 180
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Testing effectiveness (Phase 2)Ended earlyNCT04631705
What this trial is testing

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

Who this might be right for
SARS-CoV-2 Infection
University of Cologne 45
Early research (Phase 1)Not Yet RecruitingNCT07637786
What this trial is testing

Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Adenocarcinoma
Sichuan University 9
Large-scale testing (Phase 3)UnknownNCT03578341
What this trial is testing

Oral Colostrum and Its Effect on Immune System

Who this might be right for
Immune System DiseasesPremature Infant DiseaseImmunoglobulin Deficiency
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 96
Large-scale testing (Phase 3)Ended earlyNCT02398994
What this trial is testing

A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis

Who this might be right for
Myelitis, TransverseNeuromyelitis Optica
Guy's and St Thomas' NHS Foundation Trust 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Large-scale testing (Phase 3)Study completedNCT00004286
What this trial is testing

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR) 120
Testing effectiveness (Phase 2)Study completedNCT00401570
What this trial is testing

Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AbbVie (prior sponsor, Abbott) 40
Next Page